Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma

Joon Hyuk Choi,Swan N. Thung

DOI: https://doi.org/10.3390/cancers16081537

2024-04-19

Cancers

Abstract:Intrahepatic cholangiocarcinoma (ICCA) is a malignant epithelial neoplasm characterized by biliary differentiation within the liver. ICCA is molecularly heterogeneous and exhibits a broad spectrum of histopathological features. It is a highly aggressive carcinoma with high mortality and poor survival rates. ICCAs are classified into two main subtypes: the small-duct type and large-duct types. These two tumor types have different cell origins and clinicopathological features. ICCAs are characterized by numerous molecular alterations, including mutations in KRAS, TP53, IDH1/2, ARID1A, BAP1, BRAF, SAMD4, and EGFR, and FGFR2 fusion. Two main molecular subtypes—inflammation and proliferation—have been proposed. Recent advances in high-throughput assays using next-generation sequencing have improved our understanding of ICCA pathogenesis and molecular genetics. The diagnosis of ICCA poses a significant challenge for pathologists because of its varied morphologies and phenotypes. Accurate diagnosis of ICCA is essential for effective patient management and prognostic determination. This article provides an updated overview of ICCA pathology, focusing particularly on molecular features, histological subtypes, and diagnostic approaches.

oncology

What problem does this paper attempt to address?

The paper attempts to address the issue of the pathological progression of Intrahepatic Cholangiocarcinoma (ICCA). Specifically, the paper aims to provide an up-to-date review of the pathology of ICCA, with a particular focus on its molecular genetics, histological subtypes, and diagnostic methods. ICCA is a highly malignant tumor with a high mortality rate and poor survival rate. Due to its molecular heterogeneity and diverse histopathological features, accurate diagnosis of ICCA is crucial for patient management and prognosis assessment.

### The main objectives of the paper include:
1. **Overview of the pathological features of ICCA**: Including its molecular genetics, histological subtypes, and diagnostic methods.
2. **Emphasis on the molecular genetics of ICCA**: Discussing various gene mutations and fusions, such as KRAS, TP53, IDH1/2, ARID1A, BAP1, BRAF, SAMD4, EGFR, and FGFR2.
3. **Introduction of the histological subtypes of ICCA**: Divided into small duct type and large duct type, these two subtypes differ in cell origin, clinical presentation, and pathological features.
4. **Exploration of the diagnostic challenges of ICCA**: Due to the morphological diversity and phenotypic complexity of ICCA, accurate diagnosis remains challenging.
5. **Summary of the latest research progress**: Especially the application of high-throughput sequencing technology in understanding the pathogenesis and molecular genetics of ICCA.

Through these objectives, the paper hopes to provide pathologists and clinicians with the latest knowledge to better manage and treat ICCA patients.